Begin main content

Call for Patient Input: Dupixent

August 15, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dupixent Brand name Generic name Manufacturer ...

CDR Update 126

August 14, 2017
See CDR Update 126 for important news and information regarding the CADTH Common Drug Review.

New Members Join CADTH Board of Directors

August 10, 2017
CADTH is pleased to announce the election of four new members to its Board of Directors effective July 11, 2017: John Abbott, Jurisdictional (Atlantic Provinces) Mitch Moneo, Jurisdictional (Western Provinces) Ellen Pekilis, Public Dr. Charmaine Roye, Health System. The CADTH Board of Directors has overall responsibility for administering the af...

Call for Patient Input: infliximab

August 4, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. infliximab Brand name Generic name Manufacture...

CDR Update 125

August 1, 2017
See CDR Update 125 for important news and information regarding the CADTH Common Drug Review.